31 , 37 These concentrations are low and may not be significant for safety or efficacy implications.
← all excerpts
Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.
1
—
—
31 , 37 These concentrations are low and may not be significant for safety or efficacy implications.